AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G/A] CytomX Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Cytomx Therapeutics Inc

NASDAQ:CTMX

CTMX Rankings

CTMX Latest News

CTMX Latest SEC Filings

CTMX Stock Data

380.95M
163.48M
0.83%
49.81%
15.15%
Biotechnology
Pharmaceutical Preparations
United States
SOUTH SAN FRANCISCO